As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...

Scientists have turned to advanced AI to decode the intricate ecosystem of gut bacteria and their chemical signals. Using a Bayesian neural network called VBayesMM, researchers can now identify ...

A new study introduces a global probabilistic forecasting model that predicts when and where ionospheric disturbances—measured by the Rate of total electron content (TEC) Index (ROTI)—are likely to ...

Phosphodiesterase 4 (PDE4) inhibition is associated with antiinflammatory and antifibrotic effects that may be beneficial in patients with idiopathic pulmonary fibrosis. In this phase 2, double-blind, ...

In recent years, something unexpected has been happening in artificial intelligence. Modern AI appears to be breaking a rule that statisticians have preached for nearly a century: Keep models in a ...